2016 annual financial data
Neuphoria Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -294.53%.
Operating income was -21,679,785 USD and net income was -12,403,110 USD.
Operating cash flow was -15,359,554 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,214,922 USD
- Operating income
- -21,679,785 USD
- Net income
- -12,403,110 USD
- Operating cash flow
- -15,359,554 USD